Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Cellular Signaling

Background:

• The lungs are vital for respiration but susceptible to damage from various factors, leading to severe lung diseases.
• Nerve growth factor (NGF), a polypeptide abundant in lung tissue, plays a role in lung disease development.
• NGF influences disease progression by modulating protein expression and cell functions within different lung microenvironments.

Purpose of the Study:

• To review the multifaceted roles of Nerve Growth Factor (NGF) in the pathogenesis of major lung diseases.
• To explore the underlying molecular mechanisms by which NGF contributes to lung pathologies.
• To evaluate the therapeutic potential of targeting NGF in pulmonary diseases.

Main Methods:

• Literature review of studies investigating Nerve Growth Factor (NGF) in lung diseases.
• Analysis of research on NGF's involvement in cellular functions and protein expression.
• Synthesis of findings related to NGF in pulmonary fibrosis, COVID-19, pulmonary hypertension, asthma, COPD, and lung cancer.

Main Results:

• NGF is implicated in the development and progression of pulmonary fibrosis (PF), COVID-19, pulmonary hypertension (PH), asthma, chronic obstructive pulmonary disease (COPD), and lung cancer.
• NGF exerts its effects by altering protein expression and mediating cellular functions within the lung.
• Specific mechanisms linking NGF to these diverse lung conditions have been identified.

Conclusions:

• Nerve Growth Factor (NGF) is a significant factor in the pathophysiology of numerous lung diseases.
• Understanding NGF's role provides insights into disease mechanisms.
• Anti-NGF therapies represent a promising future direction for treating lung diseases.